-

Butterfly Network Announces Successful Investor Day

Announces Revenue Goal of over $500 million by 2030 and Cashflow Break-Even by end of 2027

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, hosted its first investor day under President, Chief Executive Officer and Chairman, Joseph DeVivo. The event featured presentations from members of Butterfly’s executive and senior leadership team, providing insights into the Company’s product, software and services portfolio within its core point-of-care ultrasound market, as well as its strategic initiatives to expand into new markets.

During the event, management introduced its plan to build and deploy a HomeCare Services business, and revealed the initial business models for bladder and lung HomeCare with phased rollouts that allow increasing levels of patient autonomy - from In-Home Service partnerships to patient self-scanning to wearable technology monitoring (upon appropriate regulatory clearance of the latter two steps). The program included live human demonstrations with working prototypes of Butterfly’s next-generation wearable devices.

Also included in the event were innovative showcases on Butterfly iQ3™, Butterfly Compass™ Software and Butterfly Vet, as well as strategic Powered by Butterfly™ partners (Forest Neurotech, Mendaera) and select Butterfly Garden™ partners (Deepecho, iCardio.ai, ThinkSono, University of North Carolina School of Medicine) introducing AI applications and novel products that are in co-development.

“The goal of our Investor Day was to show stakeholders that Butterfly’s success is inevitable. We’re leading the digital revolution in ultrasound. Our newly launched feature-rich Butterfly iQ3 is just the beginning; we have an exciting roadmap that takes us deeper into the hospitals, as well as into the home,” DeVivo said. “POCUS is here to stay, and the market is scaling as the next-generation of doctors learn it and healthcare systems prioritize efficiency. Butterfly is the complete solution to match this scale; we are enterprise ready and can serve all POCUS use cases today.”

Business Outlook

Butterfly announced the financial goals of achieving cash flow breakeven by the end of 2027 and to exceed $500 million in revenue by 2030.

Butterfly’s previously issued guidance for fiscal year 2024:

  • Low double-digit Revenue growth
  • Adjusted EBITDA loss of $60 million to $50 million.

A webcast replay of the event will be available on Butterfly’s Events & Presentations page on the investor relations website.

About Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission is to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: butterflynetwork.com/choose-your-country.

Contacts

Butterfly Investors:
Heather Getz
Chief Financial and Operations Officer, Butterfly
investors@butterflynetwork.com

or

Neal Nagarajan
IR Agency Representative, Sloane & Company
(301) 273-5662
nnagarajan@sloanepr.com

Butterfly Network, Inc.

NYSE:BFLY

Release Versions

Contacts

Butterfly Investors:
Heather Getz
Chief Financial and Operations Officer, Butterfly
investors@butterflynetwork.com

or

Neal Nagarajan
IR Agency Representative, Sloane & Company
(301) 273-5662
nnagarajan@sloanepr.com

More News From Butterfly Network, Inc.

Butterfly Network Achieves GovRAMP and TX-RAMP Information Security Certifications

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that its Butterfly iQ+/iQ3 and Compass AI™ ultrasound solution have achieved GovRAMP and TX-RAMP Authorizations. The certifications authorize the Company to sell cloud services to all state and local government agencies, including in the state of Texas. GovRA...

Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer...

Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2025 Revenue Growth of at least 17% Year over Year

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”, “the company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2025 of at least 17% year over year. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “We enter 2026 with strong momentum and...
Back to Newsroom